Viewing Study NCT01732861


Ignite Creation Date: 2025-12-24 @ 12:12 PM
Ignite Modification Date: 2026-03-31 @ 2:10 PM
Study NCT ID: NCT01732861
Status: COMPLETED
Last Update Posted: 2019-12-20
First Post: 2012-11-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma
Sponsor: Celgene
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module